{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:49:28Z","timestamp":1791456568689,"version":"4.3.4"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Program of Liaoning Provincial Science and Technology Plan (Natural Science Foundation \u2013 Doctoral Research Startup Project).","award":["No. 2025-BSLH-383"],"award-info":[{"award-number":["No. 2025-BSLH-383"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03405-4","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:51:40Z","timestamp":1791453100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-associated mitochondrial homeostasis disrupted and retrograde signaling activated"],"prefix":"10.1007","volume":"43","author":[{"given":"Pinya","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"3405_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148:1145\u201359. https:\/\/doi.org\/10.1016\/j.cell.2012.02.035.","journal-title":"Cell"},{"key":"3405_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.devcel.2021.02.009","volume":"56","author":"MYW Ng","year":"2021","unstructured":"Ng MYW, Wai T, Simonsen A. Quality control of the mitochondrion. Dev Cell. 2021;56:881\u2013905. https:\/\/doi.org\/10.1016\/j.devcel.2021.02.009.","journal-title":"Dev Cell"},{"key":"3405_CR3","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95:912\u20139. https:\/\/doi.org\/10.1080\/09553002.2019.1589653.","journal-title":"Int J Radiat Biol"},{"key":"3405_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2017.05.002","volume":"47","author":"P Deng","year":"2017","unstructured":"Deng P, Haynes CM. Mitochondrial dysfunction in cancer: potential roles of ATF5 and the mitochondrial UPR. Semin Cancer Biol. 2017;47:43\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2017.05.002.","journal-title":"Semin Cancer Biol"},{"key":"3405_CR5","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/jp278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the warburg effect: historical dogma versus current understanding. J Physiol. 2021;599:1745\u201357. https:\/\/doi.org\/10.1113\/jp278810.","journal-title":"J Physiol"},{"key":"3405_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2025.109285","volume":"248","author":"R Vostatek","year":"2025","unstructured":"Vostatek R, Trappl M, Englisch C, Hohensinner P, Preusser M, Pabinger I, et al. Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer. Thromb Res. 2025;248:109285. https:\/\/doi.org\/10.1016\/j.thromres.2025.109285.","journal-title":"Thromb Res"},{"key":"3405_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3325\/cmj.2024.65.111","volume":"65","author":"S Khair","year":"2024","unstructured":"Khair S, Ab Radzak SM, Idris Z, Zin AAM, Ahmad W, Yusoff AAM. The effect of somatic mutations in mitochondrial DNA on the survival of patients with primary brain tumors. Croat Med J. 2024;65:111\u201321. https:\/\/doi.org\/10.3325\/cmj.2024.65.111. (PMID: 38706237IF: 2.1 Q2 B4).","journal-title":"Croat Med J"},{"key":"3405_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15237-5","volume":"11","author":"B Sch\u00f6pf","year":"2020","unstructured":"Sch\u00f6pf B, Weissensteiner H, Sch\u00e4fer G, Fazzini F, Charoentong P, Naschberger A, et al. Oxphos remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation. Nat Commun. 2020;11:1487. https:\/\/doi.org\/10.1038\/s41467-020-15237-5.","journal-title":"Nat Commun"},{"key":"3405_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233461","volume":"15","author":"R Omasanggar","year":"2020","unstructured":"Omasanggar R, Yu CY, Ang GY, Emran NA, Kitan N, Baghawi A, et al. Mitochondrial DNA mutations in Malaysian female breast cancer patients. PLoS ONE. 2020;15:e0233461. https:\/\/doi.org\/10.1371\/journal.pone.0233461.","journal-title":"PLoS ONE"},{"key":"3405_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.7150\/jca.62278","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Tian J, Peng F, Wang J. Hypermethylation of mitochondrial DNA facilitates bone metastasis of renal cell carcinoma. J Cancer. 2022;13:304\u201312. https:\/\/doi.org\/10.7150\/jca.62278.","journal-title":"J Cancer"},{"key":"3405_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-3-32","volume":"3","author":"FO Aikhionbare","year":"2008","unstructured":"Aikhionbare FO, Mehrabi S, Thompson W, Yao X, Grizzle W, Partridge E. Mtdna sequence variants in subtypes of epithelial ovarian cancer stages in relation to ethnic and age difference. Diagn Pathol. 2008;3:32. https:\/\/doi.org\/10.1186\/1746-1596-3-32.","journal-title":"Diagn Pathol"},{"key":"3405_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.critrevonc.2017.07.001","volume":"117","author":"A Cormio","year":"2017","unstructured":"Cormio A, Sanguedolce F, Musicco C, Pesce V, Cal\u00f2 G, Bufo P, et al. Mitochondrial dysfunctions in bladder cancer: exploring their role as disease markers and potential therapeutic targets. Crit Rev Oncol Hematol. 2017;117:67\u201372. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.07.001.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3405_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2022.110315","volume":"114","author":"J Almeida","year":"2022","unstructured":"Almeida J, P\u00e9rez-Figueroa A, Alves JM, Valecha M, Prado-L\u00f3pez S, Alvari\u00f1o P, et al. Single-cell mtdna heteroplasmy in colorectal cancer. Genomics. 2022;114:110315. https:\/\/doi.org\/10.1016\/j.ygeno.2022.110315.","journal-title":"Genomics"},{"key":"3405_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-981-10-6674-0_2","volume":"1038","author":"F Liu","year":"2017","unstructured":"Liu F, Sanin DE, Wang X. Mitochondrial DNA in lung cancer. Adv Exp Med Biol. 2017;1038:9\u201322. https:\/\/doi.org\/10.1007\/978-981-10-6674-0_2. (PMID: 29178066IF: NA NA NA).","journal-title":"Adv Exp Med Biol"},{"key":"3405_CR15","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.3748\/wjg.v20.i14.3950","volume":"20","author":"HC Lee","year":"2014","unstructured":"Lee HC, Huang KH, Yeh TS, Chi CW. Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression. World J Gastroenterol. 2014;20:3950\u20139. https:\/\/doi.org\/10.3748\/wjg.v20.i14.3950. (PMID: 24744584IF: 7.7 Q1 B3).","journal-title":"World J Gastroenterol"},{"key":"3405_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111329","volume":"122","author":"A Sharma","year":"2024","unstructured":"Sharma A, Virmani T, Kumar G, Sharma A, Virmani R, Gugulothu D, et al. Mitochondrial signaling pathways and their role in cancer drug resistance. Cell Signal. 2024;122:111329. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111329.","journal-title":"Cell Signal"},{"key":"3405_CR17","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1002\/1878-0261.13291","volume":"16","author":"ALM Smith","year":"2022","unstructured":"Smith ALM, Whitehall JC, Greaves LC. Mitochondrial DNA mutations in ageing and cancer. Mol Oncol. 2022;16:3276\u201394. https:\/\/doi.org\/10.1002\/1878-0261.13291.","journal-title":"Mol Oncol"},{"key":"3405_CR18","doi-asserted-by":"publisher","unstructured":"Reznik E, Miller ML, \u015eenbabao\u011flu Y, Riaz N, Sarungbam J, Tickoo SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, et al. Mitochondrial DNA copy number variation across human cancers. Elife. 2016;5. https:\/\/doi.org\/10.7554\/eLife.10769. PMID: 26901439IF: NA NA B1.","DOI":"10.7554\/eLife.10769"},{"key":"3405_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-024-01669-3","volume":"24","author":"MS Alwehaidah","year":"2024","unstructured":"Alwehaidah MS, Al-Awadhi R, Roomy MA, Baqer TA. Mitochondrial DNA copy number and risk of papillary thyroid carcinoma. BMC Endocr Disord. 2024;24:138. https:\/\/doi.org\/10.1186\/s12902-024-01669-3.","journal-title":"BMC Endocr Disord"},{"key":"3405_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-024-06783-y","volume":"17","author":"PC Limardi","year":"2024","unstructured":"Limardi PC, Panigoro SS, Siregar NC, Sutandyo N, Witjaksono F, Priliani L, et al. Higher peripheral blood mitochondrial DNA copy number and relative telomere length in under 48\u00a0years Indonesian breast cancer patients. BMC Res Notes. 2024;17:120. https:\/\/doi.org\/10.1186\/s13104-024-06783-y.","journal-title":"BMC Res Notes"},{"key":"3405_CR21","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.5301\/jbm.5000211","volume":"31","author":"Y Wang","year":"2016","unstructured":"Wang Y, He S, Zhu X, Qiao W, Zhang J. High copy number of mitochondrial DNA predicts poor prognosis in patients with advanced stage colon cancer. Int J Biol Markers. 2016;31:e382\u20138. https:\/\/doi.org\/10.5301\/jbm.5000211.","journal-title":"Int J Biol Markers"},{"key":"3405_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-110","volume":"13","author":"H Cui","year":"2013","unstructured":"Cui H, Huang P, Wang Z, Zhang Y, Zhang Z, Xu W, et al. Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer. 2013;13:110. https:\/\/doi.org\/10.1186\/1471-2407-13-110.","journal-title":"BMC Cancer"},{"key":"3405_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167556","volume":"1871","author":"S Miklovicova","year":"2025","unstructured":"Miklovicova S, Volpini L, Sanovec O, Monaco F, Vanova KH, Novak J, et al. Mitochondrial respiratory complex ii is altered in renal carcinoma. Biochimica et Biophysica Acta (BBA). 2025;1871:167556. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167556.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3405_CR24","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ijc.34833","volume":"154","author":"X Cai","year":"2024","unstructured":"Cai X, Liang C, Zhang M, Dong Z, Weng Y, Yu W. Mitochondrial DNA copy number and cancer risks: a comprehensive mendelian randomization analysis. Int J Cancer. 2024;154:1504\u201313. https:\/\/doi.org\/10.1002\/ijc.34833.","journal-title":"Int J Cancer"},{"key":"3405_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.clinbiochem.2013.04.009","volume":"46","author":"YL Hou","year":"2013","unstructured":"Hou YL, Chen JJ, Wu YF, Xue CJ, Li FZ, Zheng Q, et al. Clinical significance of serum mitochondrial DNA in lung cancer. Clin Biochem. 2013;46:1474\u20137. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.04.009.","journal-title":"Clin Biochem"},{"key":"3405_CR26","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.7150\/jca.61379","volume":"12","author":"GP Zou","year":"2021","unstructured":"Zou GP, Yu CX, Shi SL, Li QG, Wang XH, Qu XH, et al. Mitochondrial dynamics mediated by drp1 and mfn2 contributes to cisplatin chemoresistance in human ovarian cancer skov3 cells. J Cancer. 2021;12:7358\u201373. https:\/\/doi.org\/10.7150\/jca.61379.","journal-title":"J Cancer"},{"key":"3405_CR27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41418-022-00974-5","volume":"29","author":"X Xiong","year":"2022","unstructured":"Xiong X, Hasani S, Young LEA, Rivas DR, Skaggs AT, Martinez R, et al. Activation of DRP1 promotes fatty acids-induced metabolic reprograming to potentiate WNT signaling in colon cancer. Cell Death Differ. 2022;29:1913\u201327. https:\/\/doi.org\/10.1038\/s41418-022-00974-5.","journal-title":"Cell Death Differ"},{"key":"3405_CR28","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/1878-0261.13212","volume":"16","author":"TL Huang","year":"2022","unstructured":"Huang TL, Chang CR, Chien CY, Huang GK, Chen YF, Su LJ, et al. DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1\/MMP12 axis. Mol Oncol. 2022;16:2585\u2013606. https:\/\/doi.org\/10.1002\/1878-0261.13212.","journal-title":"Mol Oncol"},{"key":"3405_CR29","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1111\/cas.14603","volume":"111","author":"M Hu","year":"2020","unstructured":"Hu M, Zhao Y, Cao Y, Tang Q, Feng Z, Ni J, et al. DRP1 promotes lactate utilization in KRAS-mutant non-small-cell lung cancer cells. Cancer Sci. 2020;111:3588\u201399. https:\/\/doi.org\/10.1111\/cas.14603.","journal-title":"Cancer Sci"},{"key":"3405_CR30","doi-asserted-by":"publisher","first-page":"65001","DOI":"10.18632\/oncotarget.11339","volume":"7","author":"L Zhan","year":"2016","unstructured":"Zhan L, Cao H, Wang G, Lyu Y, Sun X, An J, et al. Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and nf-\u03bab pathways in hepatocellular carcinoma. Oncotarget. 2016;7:65001\u201311. https:\/\/doi.org\/10.18632\/oncotarget.11339. (PMID: 27542250IF: NA NA NA).","journal-title":"Oncotarget"},{"key":"3405_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05721-3","volume":"14","author":"P Chen","year":"2023","unstructured":"Chen P, Lu Y, He B, Xie T, Yan C, Liu T, et al. Rab32 promotes glioblastoma migration and invasion via regulation of ERK\/DRP1-mediated mitochondrial fission. Cell Death Dis. 2023;14:198. https:\/\/doi.org\/10.1038\/s41419-023-05721-3.","journal-title":"Cell Death Dis"},{"key":"3405_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s43018-023-00563-6","volume":"4","author":"PK Parida","year":"2023","unstructured":"Parida PK, Marquez-Palencia M, Ghosh S, Khandelwal N, Kim K, Nair V, et al. Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases. Nat Cancer. 2023;4:893\u2013907. https:\/\/doi.org\/10.1038\/s43018-023-00563-6.","journal-title":"Nat Cancer"},{"key":"3405_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02304-6","volume":"41","author":"M Zamberlan","year":"2022","unstructured":"Zamberlan M, Boeckx A, Muller F, Vinelli F, Ek O, Vianello C, et al. Inhibition of the mitochondrial protein OPA1 curtails breast cancer growth. J Exp Clin Cancer Res. 2022;41:95. https:\/\/doi.org\/10.1186\/s13046-022-02304-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"3405_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010121","author":"M Li","year":"2020","unstructured":"Li M, Wang L, Wang Y, Zhang S, Zhou G, Lieshout R, et al. Mitochondrial fusion via OPA1 and MFN1 supports liver tumor cell metabolism and growth. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9010121.","journal-title":"Cells"},{"key":"3405_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00232-4","author":"Z Javed","year":"2024","unstructured":"Javed Z, Shin DH, Pan W, White SR, Elhaw AT, Kim YS, et al. DRP1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progression. EMBO Rep. 2024. https:\/\/doi.org\/10.1038\/s44319-024-00232-4.","journal-title":"EMBO Rep"},{"key":"3405_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-025-02252-4","volume":"31","author":"R Roy","year":"2026","unstructured":"Roy R, Adhikary A, De R, Ghosh S. Mitochondria-ER crosstalk via MAMs: bridging cellular homeostasis and cancer progression. Apoptosis. 2026;31:43. https:\/\/doi.org\/10.1007\/s10495-025-02252-4.","journal-title":"Apoptosis"},{"key":"3405_CR37","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","volume":"18","author":"CJ Pirozzi","year":"2021","unstructured":"Pirozzi CJ, Yan H (2021) The implications of idh mutations for cancer development and therapy. Nat Rev Clin Oncol 18:645\u2013661. https:\/\/doi.org\/10.1038\/s41571-021-00521-0. (PMID: 34131315 IF: 94.6 Q1 B1)","journal-title":"Nat Rev Clin Oncol"},{"key":"3405_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molmed.2010.07.002","volume":"16","author":"L Dang","year":"2010","unstructured":"Dang L, Jin S, Su SM. IDH mutations in glioma and acute myeloid leukemia. Trends Mol Med. 2010;16:387\u201397. https:\/\/doi.org\/10.1016\/j.molmed.2010.07.002.","journal-title":"Trends Mol Med"},{"key":"3405_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1158\/1078-0432.Ccr-20-1827","volume":"27","author":"MS Waitkus","year":"2021","unstructured":"Waitkus MS, Yan H. Targeting isocitrate dehydrogenase mutations in cancer: emerging evidence and diverging strategies. Clin Cancer Res. 2021;27:383\u20138. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-1827.","journal-title":"Clin Cancer Res"},{"key":"3405_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001;69:49\u201354. https:\/\/doi.org\/10.1086\/321282.","journal-title":"Am J Hum Genet"},{"key":"3405_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2019.04.013","volume":"98","author":"E Dalla Pozza","year":"2020","unstructured":"Dalla Pozza E, Dando I, Pacchiana R, Liboi E, Scupoli MT, Donadelli M, et al. Regulation of succinate dehydrogenase and role of succinate in cancer. Semin Cell Dev Biol. 2020;98:4\u201314. https:\/\/doi.org\/10.1016\/j.semcdb.2019.04.013.","journal-title":"Semin Cell Dev Biol"},{"key":"3405_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.680609","volume":"12","author":"G Pitsava","year":"2021","unstructured":"Pitsava G, Settas N, Faucz FR, Stratakis CA. Carney triad, Carney-Stratakis syndrome, 3pas and other tumors due to SDH deficiency. Front Endocrinol (Lausanne). 2021;12:680609. https:\/\/doi.org\/10.3389\/fendo.2021.680609.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3405_CR43","doi-asserted-by":"publisher","unstructured":"Li P, Wu Y, Wu H, Xiong Q, Zhao N, Chen G, Wu C, Xiao H. Functional characterization of fh mutation c.557g>a underlies uterine leiomyomas. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23031452. PMID: 35163394 IF: 5.6 Q1 B3.","DOI":"10.3390\/ijms23031452"},{"key":"3405_CR44","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S et al (2002) Germline mutations in fh predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406\u2013410. https:\/\/doi.org\/10.1038\/ng849. (PMID: 11865300 IF: 25.5 Q1 B1)","journal-title":"Nat Genet"},{"key":"3405_CR45","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/sj.ejhg.5201630","volume":"14","author":"SK Ylisaukko-oja","year":"2006","unstructured":"Ylisaukko-oja SK, Cybulski C, Lehtonen R, Kiuru M, Matyjasik J, Szyma\u00f1ska A, et al. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma. Eur J Hum Genet. 2006;14:880\u20133. https:\/\/doi.org\/10.1038\/sj.ejhg.5201630.","journal-title":"Eur J Hum Genet"},{"key":"3405_CR46","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1002\/cncr.32914","volume":"126","author":"B Shuch","year":"2020","unstructured":"Shuch B, Li S, Risch H, Bindra RS, McGillivray PD, Gerstein M. Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer. Cancer. 2020;126:3657\u201366. https:\/\/doi.org\/10.1002\/cncr.32914.","journal-title":"Cancer"},{"key":"3405_CR47","doi-asserted-by":"publisher","first-page":"38777","DOI":"10.18632\/oncotarget.6091","volume":"6","author":"AS Hoekstra","year":"2015","unstructured":"Hoekstra AS, de Graaff MA, Briaire-de Bruijn IH, Ras C, Seifar RM, van Minderhout I, Cornelisse CJ, Hogendoorn PC, Breuning MH, Suijker J et al (2015) Inactivation of sdh and fh cause loss of 5hmc and increased h3k9me3 in paraganglioma\/pheochromocytoma and smooth muscle tumors. Oncotarget 6:38777\u201338788. https:\/\/doi.org\/10.18632\/oncotarget.6091. (PMID: 26472283 IF: NA NA NA)","journal-title":"Oncotarget"},{"key":"3405_CR48","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.celrep.2017.09.092","volume":"21","author":"PA Tyrakis","year":"2017","unstructured":"Tyrakis PA, Yurkovich ME, Sciacovelli M, Papachristou EK, Bridges HR, Gaude E, et al. Fumarate hydratase loss causes combined respiratory chain defects. Cell Rep. 2017;21:1036\u201347. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.092. (PMID: 29069586IF: 7.7 Q1 B1).","journal-title":"Cell Rep"},{"key":"3405_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194817","author":"SR Ali","year":"2022","unstructured":"Ali SR, Jordan M, Nagarajan P, Amit M. Nerve density and neuronal biomarkers in cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194817.","journal-title":"Cancers (Basel)"},{"key":"3405_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-020-05652-z","volume":"182","author":"C Ezratty","year":"2020","unstructured":"Ezratty C, Vang S, Brown J, Margolies LR, Jandorf L, Lin JJ. Racial\/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts. Breast Cancer Res Treat. 2020;182:181\u20135. https:\/\/doi.org\/10.1007\/s10549-020-05652-z.","journal-title":"Breast Cancer Res Treat"},{"key":"3405_CR51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.trecan.2023.11.008","volume":"10","author":"M Hashimoto","year":"2024","unstructured":"Hashimoto M, Ramalingam SS, Ahmed R. Harnessing CD8 T cell responses using PD-1-IL-2 combination therapy. Trends Cancer. 2024;10:332\u201346. https:\/\/doi.org\/10.1016\/j.trecan.2023.11.008.","journal-title":"Trends Cancer"},{"key":"3405_CR52","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.mito.2013.08.007","volume":"13","author":"M Guha","year":"2013","unstructured":"Guha M, Avadhani NG. Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion. 2013;13:577\u201391. https:\/\/doi.org\/10.1016\/j.mito.2013.08.007.","journal-title":"Mitochondrion"},{"key":"3405_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev.genet.40.110405.090613","volume":"40","author":"Z Liu","year":"2006","unstructured":"Liu Z, Butow RA. Mitochondrial retrograde signaling. Annu Rev Genet. 2006;40:159\u201385. https:\/\/doi.org\/10.1146\/annurev.genet.40.110405.090613.","journal-title":"Annu Rev Genet"},{"key":"3405_CR54","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/1535370220920558","volume":"245","author":"SF Wang","year":"2020","unstructured":"Wang SF, Chen S, Tseng LM, Lee HC. Role of the mitochondrial stress response in human cancer progression. Exp Biol Med (Maywood). 2020;245:861\u201378. https:\/\/doi.org\/10.1177\/1535370220920558.","journal-title":"Exp Biol Med (Maywood)"},{"key":"3405_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397. https:\/\/doi.org\/10.1038\/s41568-021-00435-0.","journal-title":"Nat Rev Cancer"},{"key":"3405_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.freeradbiomed.2016.04.198","volume":"100","author":"L Diebold","year":"2016","unstructured":"Diebold L, Chandel NS. Mitochondrial ROS regulation of proliferating cells. Free Radic Biol Med. 2016;100:86\u201393. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.04.198.","journal-title":"Free Radic Biol Med"},{"key":"3405_CR57","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1073\/pnas.1003428107","volume":"107","author":"F Weinberg","year":"2010","unstructured":"Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for KRAS-mediated tumorigenicity. Proc Natl Acad Sci U S A. 2010;107:8788\u201393. https:\/\/doi.org\/10.1073\/pnas.1003428107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3405_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-022-05426-1","volume":"612","author":"M Schmitt","year":"2022","unstructured":"Schmitt M, Ceteci F, Gupta J, Pesic M, B\u00f6ttger TW, Nicolas AM, et al. Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation. Nature. 2022;612:347\u201353. https:\/\/doi.org\/10.1038\/s41586-022-05426-1.","journal-title":"Nature"},{"key":"3405_CR59","doi-asserted-by":"publisher","first-page":"12465","DOI":"10.1007\/s13277-016-5101-3","volume":"37","author":"L Wallace","year":"2016","unstructured":"Wallace L, Mehrabi S, Bacanamwo M, Yao X, Aikhionbare FO. Expression of mitochondrial genes mt-nd1, mt-nd6, mt-cyb, mt-coi, mt-atp6, and 12s\/mt-rnr1 in colorectal adenopolyps. Tumour Biol. 2016;37:12465\u201375. https:\/\/doi.org\/10.1007\/s13277-016-5101-3. (PMID: 27333991IF: NA NA NA).","journal-title":"Tumour Biol"},{"key":"3405_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/482582","author":"FM da Cunha","year":"2015","unstructured":"da Cunha FM, Torelli NQ, Kowaltowski AJ. Mitochondrial retrograde signaling: triggers, pathways, and outcomes. Oxid Med Cell Longev. 2015. https:\/\/doi.org\/10.1155\/2015\/482582.","journal-title":"Oxid Med Cell Longev"},{"key":"3405_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103285","volume":"160","author":"R Malla","year":"2021","unstructured":"Malla R, Surepalli N, Farran B, Malhotra SV, Nagaraju GP. Reactive oxygen species (ROS): critical roles in breast tumor microenvironment. Crit Rev Oncol Hematol. 2021;160:103285. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103285.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3405_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155747","volume":"151","author":"R Shah","year":"2024","unstructured":"Shah R, Ibis B, Kashyap M, Boussiotis VA. The role of ROS in tumor infiltrating immune cells and cancer immunotherapy. Metabolism. 2024;151:155747. https:\/\/doi.org\/10.1016\/j.metabol.2023.155747.","journal-title":"Metabolism"},{"key":"3405_CR63","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.canlet.2020.01.019","volume":"474","author":"CL Kuo","year":"2020","unstructured":"Kuo CL, Chou HY, Chiu YC, Cheng AN, Fan CC, Chang YN, et al. Mitochondrial oxidative stress by LON-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis. Cancer Lett. 2020;474:138\u201350. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.019.","journal-title":"Cancer Lett"},{"key":"3405_CR64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.semcdb.2019.05.029","volume":"98","author":"F Ferro","year":"2020","unstructured":"Ferro F, Servais S, Besson P, Roger S, Dumas JF, Brisson L. Autophagy and mitophagy in cancer metabolic remodelling. Semin Cell Dev Biol. 2020;98:129\u201338. https:\/\/doi.org\/10.1016\/j.semcdb.2019.05.029.","journal-title":"Semin Cell Dev Biol"},{"key":"3405_CR65","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1080\/15548627.2021.2008752","volume":"18","author":"Y Xing","year":"2022","unstructured":"Xing Y, Wei X, Liu Y, Wang MM, Sui Z, Wang X, et al. Autophagy inhibition mediated by mcoln1\/trpml1 suppresses cancer metastasis via regulating a ROS-driven tp53\/p53 pathway. Autophagy. 2022;18:1932\u201354. https:\/\/doi.org\/10.1080\/15548627.2021.2008752.","journal-title":"Autophagy"},{"key":"3405_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-42667-5_1","volume":"1260","author":"L Gao","year":"2020","unstructured":"Gao L, Loveless J, Shay C, Teng Y (2020) Targeting ros-mediated crosstalk between autophagy and apoptosis in cancer. Adv Exp Med Biol 1260:1\u201312. https:\/\/doi.org\/10.1007\/978-3-030-42667-5_1. (PMID: 32304028 IF: NA NA NA)","journal-title":"Adv Exp Med Biol"},{"key":"3405_CR67","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1096\/fj.15-275404","volume":"29","author":"AO Oyewole","year":"2015","unstructured":"Oyewole AO, Birch-Machin MA. Mitochondria-targeted antioxidants. FASEB J. 2015;29:4766\u201371. https:\/\/doi.org\/10.1096\/fj.15-275404.","journal-title":"FASEB J"},{"key":"3405_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00747-0","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Fan Y, Cao P, Tan K. Insight into the mitochondrial unfolded protein response and cancer: opportunities and challenges. Cell Biosci. 2022;12:18. https:\/\/doi.org\/10.1186\/s13578-022-00747-0.","journal-title":"Cell Biosci"},{"key":"3405_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-020-05729-9","volume":"183","author":"FM Chen","year":"2020","unstructured":"Chen FM, Huang LJ, Ou-Yang F, Kan JY, Kao LC, Hou MF. Activation of mitochondrial unfolded protein response is associated with HER2-overexpression breast cancer. Breast Cancer Res Treat. 2020;183:61\u201370. https:\/\/doi.org\/10.1007\/s10549-020-05729-9.","journal-title":"Breast Cancer Res Treat"},{"key":"3405_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111789","volume":"41","author":"D Chamseddine","year":"2022","unstructured":"Chamseddine D, Mahmud SA, Westfall AK, Castoe TA, Berg RE, Pellegrino MW. The mitochondrial upr regulator atf5 promotes intestinal barrier function via control of the satiety response. Cell Rep. 2022;41:111789. https:\/\/doi.org\/10.1016\/j.celrep.2022.111789.","journal-title":"Cell Rep"},{"key":"3405_CR71","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbabio.2017.01.004","volume":"1858","author":"S Srinivasan","year":"2017","unstructured":"Srinivasan S, Guha M, Kashina A, Avadhani NG. Mitochondrial dysfunction and mitochondrial dynamics-the cancer connection. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2017;1858:602\u201314. https:\/\/doi.org\/10.1016\/j.bbabio.2017.01.004.","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"key":"3405_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.747837","volume":"12","author":"X Tian","year":"2021","unstructured":"Tian X, Zhang S, Zhou L, Seyhan AA, Hernandez Borrero L, Zhang Y, et al. Targeting the integrated stress response in cancer therapy. Front Pharmacol. 2021;12:747837. https:\/\/doi.org\/10.3389\/fphar.2021.747837.","journal-title":"Front Pharmacol"},{"key":"3405_CR73","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1038\/emboj.2010.81","volume":"29","author":"J Ye","year":"2010","unstructured":"Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN, et al. The gcn2-atf4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 2010;29:2082\u201396. https:\/\/doi.org\/10.1038\/emboj.2010.81.","journal-title":"EMBO J"},{"key":"3405_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137129","author":"P Paerhati","year":"2022","unstructured":"Paerhati P, Liu J, Jin Z, Jako\u0161 T, Zhu S, Qian L, et al. Advancements in activating transcription factor 5 function in regulating cell stress and survival. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23137129.","journal-title":"Int J Mol Sci"},{"key":"3405_CR75","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.cub.2016.06.002","volume":"26","author":"CJ Fiorese","year":"2016","unstructured":"Fiorese CJ, Schulz AM, Lin YF, Rosin N, Pellegrino MW, Haynes CM. The transcription factor atf5 mediates a mammalian mitochondrial upr. Curr Biol. 2016;26:2037\u201343. https:\/\/doi.org\/10.1016\/j.cub.2016.06.002.","journal-title":"Curr Biol"},{"key":"3405_CR76","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/PGP.0b013e31824df26b","volume":"31","author":"A Chen","year":"2012","unstructured":"Chen A, Qian D, Wang B, Hu M, Lu J, Qi Y, et al. Atf5 is overexpressed in epithelial ovarian carcinomas and interference with its function increases apoptosis through the downregulation of bcl-2 in skov-3 cells. Int J Gynecol Pathol. 2012;31:532\u20137. https:\/\/doi.org\/10.1097\/PGP.0b013e31824df26b.","journal-title":"Int J Gynecol Pathol"},{"key":"3405_CR77","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41577-023-00838-0","volume":"23","author":"G Di Conza","year":"2023","unstructured":"Di Conza G, Ho PC, Cubillos-Ruiz JR, Huang SC. Control of immune cell function by the unfolded protein response. Nat Rev Immunol. 2023;23:546\u201362. https:\/\/doi.org\/10.1038\/s41577-023-00838-0.","journal-title":"Nat Rev Immunol"},{"key":"3405_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53039-1","volume":"15","author":"B Unal","year":"2024","unstructured":"Unal B, Kuzu OF, Jin Y, Osorio D, Kildal W, Pradhan M, et al. Targeting ire1\u03b1 reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer. Nat Commun. 2024;15:8895. https:\/\/doi.org\/10.1038\/s41467-024-53039-1.","journal-title":"Nat Commun"},{"key":"3405_CR79","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1158\/0008-5472.Can-19-3108","volume":"80","author":"JM Harnoss","year":"2020","unstructured":"Harnoss JM, Le Thomas A, Reichelt M, Guttman O, Wu TD, Marsters SA, et al. Ire1\u03b1 disruption in triple-negative breast cancer cooperates with antiangiogenic therapy by reversing er stress adaptation and remodeling the tumor microenvironment. Cancer Res. 2020;80:2368\u201379. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-3108.","journal-title":"Cancer Res"},{"key":"3405_CR80","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1007\/s00018-021-03887-7","volume":"78","author":"EM Eckl","year":"2021","unstructured":"Eckl EM, Ziegemann O, Krumwiede L, Fessler E, Jae LT. Sensing, signaling and surviving mitochondrial stress. Cell Mol Life Sci. 2021;78:5925\u201351. https:\/\/doi.org\/10.1007\/s00018-021-03887-7.","journal-title":"Cell Mol Life Sci"},{"key":"3405_CR81","doi-asserted-by":"publisher","first-page":"10893","DOI":"10.1039\/d1sc03119h","volume":"12","author":"X Hu","year":"2021","unstructured":"Hu X, Li H, Ip TK, Cheung YF, Koohi-Moghadam M, Wang H, et al. Arsenic trioxide targets HSP60, triggering degradation of P53 and survivin. Chem Sci. 2021;12:10893\u2013900. https:\/\/doi.org\/10.1039\/d1sc03119h.","journal-title":"Chem Sci"},{"key":"3405_CR82","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1073\/pnas.1300410110","volume":"110","author":"GS Williams","year":"2013","unstructured":"Williams GS, Boyman L, Chikando AC, Khairallah RJ, Lederer WJ. Mitochondrial calcium uptake. Proc Natl Acad Sci U S A. 2013;110:10479\u201386. https:\/\/doi.org\/10.1073\/pnas.1300410110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3405_CR83","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm3412","volume":"13","author":"R Rizzuto","year":"2012","unstructured":"Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol. 2012;13:566\u201378. https:\/\/doi.org\/10.1038\/nrm3412.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3405_CR84","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/cphy.c160013","volume":"7","author":"R Bravo-Sagua","year":"2017","unstructured":"Bravo-Sagua R, Parra V, L\u00f3pez-Crisosto C, D\u00edaz P, Quest AF, Lavandero S (2017) Calcium transport and signaling in mitochondria. Compr Physiol 7:623\u2013634. https:\/\/doi.org\/10.1002\/cphy.c160013. (PMID: 28333383 IF: 6.3 Q1 B2)","journal-title":"Compr Physiol"},{"key":"3405_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071576","author":"J Szyma\u0144ski","year":"2017","unstructured":"Szyma\u0144ski J, Janikiewicz J, Michalska B, Patalas-Krawczyk P, Perrone M, Zi\u00f3\u0142kowski W, et al. Interaction of mitochondria with the endoplasmic reticulum and plasma membrane in calcium homeostasis, lipid trafficking and mitochondrial structure. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18071576.","journal-title":"Int J Mol Sci"},{"key":"3405_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101370","volume":"23","author":"A Roy Chowdhury","year":"2020","unstructured":"Roy Chowdhury A, Srinivasan S, Csord\u00e1s G, Hajn\u00f3czky G, Avadhani NG. Dysregulation of ryr calcium channel causes the onset of mitochondrial retrograde signaling. iScience. 2020;23:101370. https:\/\/doi.org\/10.1016\/j.isci.2020.101370.","journal-title":"iScience"},{"key":"3405_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04668-1","volume":"13","author":"V Tangeda","year":"2022","unstructured":"Tangeda V, Lo YK, Babuharisankar AP, Chou HY, Kuo CL, Kao YH, et al. Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca(2+) release in cancer cells. Cell Death Dis. 2022;13:241. https:\/\/doi.org\/10.1038\/s41419-022-04668-1.","journal-title":"Cell Death Dis"},{"key":"3405_CR88","doi-asserted-by":"publisher","first-page":"11725","DOI":"10.18632\/oncotarget.3955","volume":"6","author":"YY Wang","year":"2015","unstructured":"Wang YY, Zhao R, Zhe H. The emerging role of CaMKII in cancer. Oncotarget. 2015;6:11725\u201334. https:\/\/doi.org\/10.18632\/oncotarget.3955.","journal-title":"Oncotarget"},{"key":"3405_CR89","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3748\/wjg.v23.i33.6111","volume":"23","author":"W Chen","year":"2017","unstructured":"Chen W, An P, Quan XJ, Zhang J, Zhou ZY, Zou LP, et al. Ca(2+)\/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1\/2 and p38 pathways. World J Gastroenterol. 2017;23:6111\u20138. https:\/\/doi.org\/10.3748\/wjg.v23.i33.6111.","journal-title":"World J Gastroenterol"},{"key":"3405_CR90","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.7150\/thno.56369","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Zhao H, Zheng L, Zhou Y, Wu L, Xu Y, et al. FGF19\/SOCE\/NFATC2 signaling circuit facilitates the self-renewal of liver cancer stem cells. Theranostics. 2021;11:5045\u201360. https:\/\/doi.org\/10.7150\/thno.56369.","journal-title":"Theranostics"},{"key":"3405_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03984-2","volume":"12","author":"Y Shi","year":"2021","unstructured":"Shi Y, Wang Y, Jiang H, Sun X, Xu H, Wei X, et al. Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca(2+)]m-PDP1-PDH-histone acetylation retrograde signaling. Cell Death Dis. 2021;12:837. https:\/\/doi.org\/10.1038\/s41419-021-03984-2.","journal-title":"Cell Death Dis"},{"key":"3405_CR92","doi-asserted-by":"publisher","first-page":"741","DOI":"10.7150\/jca.81811","volume":"14","author":"J Zhu","year":"2023","unstructured":"Zhu J, Zhang W, Chang J, Wu J, Wu H, Zhang X, et al. Identification and validation of a mitochondria calcium uptake-related gene signature for predicting prognosis in COAD. J Cancer. 2023;14:741\u201358. https:\/\/doi.org\/10.7150\/jca.81811.","journal-title":"J Cancer"},{"key":"3405_CR93","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1016\/j.molcel.2021.07.014","volume":"81","author":"DM Booth","year":"2021","unstructured":"Booth DM, V\u00e1rnai P, Joseph SK, Hajn\u00f3czky G. Oxidative bursts of single mitochondria mediate retrograde signaling toward the ER. Mol Cell. 2021;81:3866-3876.e3862. https:\/\/doi.org\/10.1016\/j.molcel.2021.07.014.","journal-title":"Mol Cell"},{"key":"3405_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01322-4","volume":"3","author":"A Blumental-Perry","year":"2020","unstructured":"Blumental-Perry A, Jobava R, Bederman I, Degar AJ, Kenche H, Guan BJ, et al. Retrograde signaling by a mtDNA-encoded non-coding RNA preserves mitochondrial bioenergetics. Commun Biol. 2020;3:626. https:\/\/doi.org\/10.1038\/s42003-020-01322-4.","journal-title":"Commun Biol"},{"key":"3405_CR95","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2018.06.008","volume":"28","author":"KH Kim","year":"2018","unstructured":"Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab. 2018;28:516-524.e517. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.008.","journal-title":"Cell Metab"},{"key":"3405_CR96","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.molcel.2018.01.037","volume":"69","author":"MD Cardamone","year":"2018","unstructured":"Cardamone MD, Tanasa B, Cederquist CT, Huang J, Mahdaviani K, Li W, et al. Mitochondrial retrograde signaling in mammals is mediated by the transcriptional cofactor GPS2 via direct mitochondria-to-nucleus translocation. Mol Cell. 2018;69:757-772.e757. https:\/\/doi.org\/10.1016\/j.molcel.2018.01.037.","journal-title":"Mol Cell"},{"key":"3405_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02713-1","volume":"42","author":"C Rupert","year":"2023","unstructured":"Rupert C, Dell\u2019 Aversana C, Mosca L, Montanaro V, Arcaniolo D, De Sio M, et al. Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models. J Exp Clin Cancer Res. 2023;42:134. https:\/\/doi.org\/10.1186\/s13046-023-02713-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"3405_CR98","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semcancer.2021.06.002","volume":"76","author":"O Cantoni","year":"2021","unstructured":"Cantoni O, Zito E, Fiorani M, Guidarelli A. Arsenite impinges on endoplasmic reticulum-mitochondria crosstalk to elicit mitochondrial ROS formation and downstream toxicity. Semin Cancer Biol. 2021;76:132\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.002.","journal-title":"Semin Cancer Biol"},{"key":"3405_CR99","doi-asserted-by":"publisher","first-page":"25018","DOI":"10.1074\/jbc.M110.111450","volume":"285","author":"A Vaarmann","year":"2010","unstructured":"Vaarmann A, Gandhi S, Abramov AY. Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase. J Biol Chem. 2010;285:25018\u201323. https:\/\/doi.org\/10.1074\/jbc.M110.111450.","journal-title":"J Biol Chem"},{"key":"3405_CR100","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1210\/me.2007-0381","volume":"22","author":"AK Rao","year":"2008","unstructured":"Rao AK, Ziegler YS, McLeod IX, Yates JR, Nardulli AM. Effects of Cu\/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Mol Endocrinol. 2008;22:1113\u201324. https:\/\/doi.org\/10.1210\/me.2007-0381.","journal-title":"Mol Endocrinol"},{"key":"3405_CR101","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD. Thirty years of Nrf2: advances and therapeutic challenges. Nat Rev Drug Discov. 2025;24:421\u201344. https:\/\/doi.org\/10.1038\/s41573-025-01145-0.","journal-title":"Nat Rev Drug Discov"},{"key":"3405_CR102","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC. Nf-\u03baB in inflammation and cancer. Cell Mol Immunol. 2025;22:811\u201339. https:\/\/doi.org\/10.1038\/s41423-025-01310-w.","journal-title":"Cell Mol Immunol"},{"key":"3405_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2081-4","volume":"10","author":"M Kleih","year":"2019","unstructured":"Kleih M, B\u00f6pple K, Dong M, Gai\u00dfler A, Heine S, Olayioye MA, et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis. 2019;10:851. https:\/\/doi.org\/10.1038\/s41419-019-2081-4.","journal-title":"Cell Death Dis"},{"key":"3405_CR104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10863-006-9059-5","volume":"39","author":"KJ Cullen","year":"2007","unstructured":"Cullen KJ, Yang Z, Schumaker L, Guo Z. Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. J Bioenerg Biomembr. 2007;39:43\u201350. https:\/\/doi.org\/10.1007\/s10863-006-9059-5.","journal-title":"J Bioenerg Biomembr"},{"key":"3405_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020320","author":"S Kasai","year":"2020","unstructured":"Kasai S, Shimizu S, Tatara Y, Mimura J, Itoh K. Regulation of nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10020320.","journal-title":"Biomolecules"},{"key":"3405_CR106","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1124\/jpet.117.241794","volume":"363","author":"JG Yonchuk","year":"2017","unstructured":"Yonchuk JG, Foley JP, Bolognese BJ, Logan G, Wixted WE, Kou JP, et al. Characterization of the potent, selective Nrf2 activator, 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2h-chromen-2-one, in cellular and in vivo models of pulmonary oxidative stress. J Pharmacol Exp Ther. 2017;363:114\u201325. https:\/\/doi.org\/10.1124\/jpet.117.241794.","journal-title":"J Pharmacol Exp Ther"},{"key":"3405_CR107","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1021\/acschembio.5b00448","volume":"10","author":"MJ Bollong","year":"2015","unstructured":"Bollong MJ, Yun H, Sherwood L, Woods AK, Lairson LL, Schultz PG. A small molecule inhibits deregulated Nrf2 transcriptional activity in cancer. ACS Chem Biol. 2015;10:2193\u20138. https:\/\/doi.org\/10.1021\/acschembio.5b00448.","journal-title":"ACS Chem Biol"},{"key":"3405_CR108","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.02.021","volume":"150","author":"MA Cucci","year":"2020","unstructured":"Cucci MA, Grattarola M, Dianzani C, Damia G, Ricci F, Roetto A, et al. Ailanthone increases oxidative stress in cddp-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and Yap expression through a post-translational mechanism. Free Radic Biol Med. 2020;150:125\u201335. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.021.","journal-title":"Free Radic Biol Med"},{"key":"3405_CR109","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12272-025-01557-x","volume":"48","author":"HH Ngo","year":"2025","unstructured":"Ngo HH, Yu BY, Lee JE, Kim H, Keum YS. Nrf2 activation in cancer and overview of nrf2 small molecule inhibitors. Arch Pharm Res. 2025;48:676\u2013705. https:\/\/doi.org\/10.1007\/s12272-025-01557-x.","journal-title":"Arch Pharm Res"},{"key":"3405_CR110","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2023.06.009","volume":"205","author":"G Cheng","year":"2023","unstructured":"Cheng G, Karoui H, Hardy M, Kalyanaraman B. Redox-crippled mitoq potently inhibits breast cancer and glioma cell proliferation: a negative control for verifying the antioxidant mechanism of mitoq in cancer and other oxidative pathologies. Free Radic Biol Med. 2023;205:175\u201387. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.06.009.","journal-title":"Free Radic Biol Med"},{"key":"3405_CR111","doi-asserted-by":"publisher","unstructured":"Capeloa T, Krzystyniak J, d\u2019Hose D, Canas Rodriguez A, Payen VL, Zampieri LX, Van de Velde JA, Benyahia Z, Pranzini E, Vazeille T, et al. Mitoq inhibits human breast cancer cell migration, invasion and clonogenicity. Cancers (Basel). 2022;14. https:\/\/doi.org\/10.3390\/cancers14061516. PMID: 35326667IF: 4.8 Q2 B3.","DOI":"10.3390\/cancers14061516"},{"key":"3405_CR112","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1158\/1078-0432.Ccr-21-0833","volume":"28","author":"S Wei","year":"2022","unstructured":"Wei S, Yin D, Yu S, Lin X, Savani MR, Du K, et al. Antitumor activity of a mitochondrial-targeted hsp90 inhibitor in gliomas. Clin Cancer Res. 2022;28:2180\u201395. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-0833.","journal-title":"Clin Cancer Res"},{"key":"3405_CR113","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/bjc.2011.9","volume":"104","author":"BH Kang","year":"2011","unstructured":"Kang BH, Tavecchio M, Goel HL, Hsieh CC, Garlick DS, Raskett CM, et al. Targeted inhibition of mitochondrial hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. Br J Cancer. 2011;104:629\u201334. https:\/\/doi.org\/10.1038\/bjc.2011.9.","journal-title":"Br J Cancer"},{"key":"3405_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01410-8","volume":"16","author":"H Duan","year":"2024","unstructured":"Duan H, Ren J, Wei S, Yang Z, Li C, Wang Z, et al. Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target. Genome Med. 2024;16:138. https:\/\/doi.org\/10.1186\/s13073-024-01410-8.","journal-title":"Genome Med"},{"key":"3405_CR115","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0003-9861(89)90101-x","volume":"269","author":"AD Griffith","year":"1989","unstructured":"Griffith AD, Cyr DM, Egan SG, Tremblay GC. Inhibition of pyruvate carboxylase by sequestration of coenzyme A with sodium benzoate. Arch Biochem Biophys. 1989;269:201\u20137. https:\/\/doi.org\/10.1016\/0003-9861(89)90101-x.","journal-title":"Arch Biochem Biophys"},{"key":"3405_CR116","doi-asserted-by":"publisher","unstructured":"Drizyte-Miller K, Degan SE, Mouery RD, Amparo AM, Mouery BL, Chang WH, Yang R, Nicewarner Pe\u00f1a SR, Baldelli E, Klomp JA, et al. Dordaviprone\/onc201 activation of the clpp mitochondrial protease inhibits the growth of kras-mutant pancreatic cancer and overcomes ras inhibitor resistance. bioRxiv. 2025 https:\/\/doi.org\/10.64898\/2025.12.01.691471. PMID: 41573866IF: NA NA NA.","DOI":"10.64898\/2025.12.01.691471"},{"key":"3405_CR117","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1021\/acs.jmedchem.4c01723","volume":"68","author":"M Miciaccia","year":"2025","unstructured":"Miciaccia M, Baldelli OM, Fortuna CG, Cavallaro G, Armenise D, Liturri A, et al. Onc201-derived tetrahydropyridopyrimidindiones as powerful ClpP protease activators to tackle diffuse midline glioma. J Med Chem. 2025;68:5190\u2013210. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01723.","journal-title":"J Med Chem"},{"key":"3405_CR118","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","volume":"35","author":"J Ishizawa","year":"2019","unstructured":"Ishizawa J, Zarabi SF, Davis RE, Halgas O, Nii T, Jitkova Y, et al. Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality. Cancer Cell. 2019;35:721-737.e729. https:\/\/doi.org\/10.1016\/j.ccell.2019.03.014.","journal-title":"Cancer Cell"},{"key":"3405_CR119","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jare.2024.02.013","volume":"68","author":"J Wang","year":"2025","unstructured":"Wang J, Jiang J, Hu H, Chen L. Mcu complex: exploring emerging targets and mechanisms of mitochondrial physiology and pathology. J Adv Res. 2025;68:271\u201398. https:\/\/doi.org\/10.1016\/j.jare.2024.02.013.","journal-title":"J Adv Res"},{"key":"3405_CR120","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10863-008-9158-6","volume":"40","author":"E Simamura","year":"2008","unstructured":"Simamura E, Shimada H, Hatta T, Hirai K. Mitochondrial voltage-dependent anion channels (VDACs) as novel pharmacological targets for anti-cancer agents. J Bioenerg Biomembr. 2008;40:213\u20137. https:\/\/doi.org\/10.1007\/s10863-008-9158-6.","journal-title":"J Bioenerg Biomembr"},{"key":"3405_CR121","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0896-6273(00)80384-0","volume":"19","author":"J Gafni","year":"1997","unstructured":"Gafni J, Munsch JA, Lam TH, Catlin MC, Costa LG, Molinski TF, et al. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron. 1997;19:723\u201333. https:\/\/doi.org\/10.1016\/s0896-6273(00)80384-0.","journal-title":"Neuron"},{"key":"3405_CR122","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1158\/0008-5472.Can-09-2886","volume":"70","author":"SS Kang","year":"2010","unstructured":"Kang SS, Han KS, Ku BM, Lee YK, Hong J, Shin HY, et al. Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res. 2010;70:1173\u201383. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-2886.","journal-title":"Cancer Res"},{"key":"3405_CR123","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2016.00107","volume":"4","author":"D Torralba","year":"2016","unstructured":"Torralba D, Baixauli F, S\u00e1nchez-Madrid F (2016) Mitochondria know no boundaries: Mechanisms and functions of intercellular mitochondrial transfer. Front Cell Dev Biol 4:107. https:\/\/doi.org\/10.3389\/fcell.2016.00107. (PMID: 27734015 IF: 5.3 Q1 B2)","journal-title":"Front Cell Dev Biol"},{"key":"3405_CR124","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1158\/0008-5472.Can-25-0433","volume":"86","author":"T Liu","year":"2026","unstructured":"Liu T, Huang S, Li Z, Li J, Sun Q, Wang Q, et al. Transfer of damaged mitochondria from cancer cells to cancer-associated fibroblasts promotes tyrosine kinase inhibitor tolerance in EGFR-mutant lung cancer. Cancer Res. 2026;86:1215\u201331. https:\/\/doi.org\/10.1158\/0008-5472.Can-25-0433.","journal-title":"Cancer Res"},{"key":"3405_CR125","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha T, Dash C, Jayabalan R, Khiste S, Kulkarni A, Kurmi K, et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat Nanotechnol. 2022;17:98\u2013106. https:\/\/doi.org\/10.1038\/s41565-021-01000-4.","journal-title":"Nat Nanotechnol"},{"key":"3405_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1871148","volume":"17","author":"Z Xu","year":"2026","unstructured":"Xu Z, Zhou Q, Miao J. Mitochondrial transfer in the tumor microenvironment: a dynamic determinant of cancer plasticity, immune dysfunction, and therapeutic opportunity. Front Immunol. 2026;17:1871148. https:\/\/doi.org\/10.3389\/fimmu.2026.1871148.","journal-title":"Front Immunol"},{"key":"3405_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05770-y","volume":"22","author":"X Cui","year":"2024","unstructured":"Cui X, Xu J, Jia X. Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer. J Transl Med. 2024;22:968. https:\/\/doi.org\/10.1186\/s12967-024-05770-y.","journal-title":"J Transl Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03405-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03405-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03405-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:51:42Z","timestamp":1791453102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03405-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":127,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3405"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03405-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"309"}}